<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
cerebral blood flow, antiphospholipid antibodies, autoimmune, blood brain barrier, multiple sclerosis, stroke, thrombosis, Neuroscience, cerebrovascular disease
cerebral blood flow, antiphospholipid antibodies, autoimmune, blood brain barrier, multiple sclerosis, stroke, thrombosis, Neuroscience, cerebrovascular disease
1 Marrie RA Reider N Cohen J Stuve O Trojano M Cutter G A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler (2015) 21:318–31.10.1177/1352458514564485 [OpenAIRE] [DOI]
2 Roshanisefat H Bahmanyar S Hillert J Olsson T Montgomery S. Multiple sclerosis clinical course and cardiovascular disease risk – Swedish cohort study. Eur J Neurol (2014) 21:1353–e88.10.1111/ene.12518 25041631 [OpenAIRE] [PubMed] [DOI]
3 Christiansen CF Christensen S Farkas DK Miret M Sørensen HT Pedersen L. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study. Neuroepidemiology (2010) 35:267–74.10.1159/000320245 20881430 [OpenAIRE] [PubMed] [DOI]
4 Tseng CH Huang WS Lin CL Chang YJ. Increased risk of ischaemic stroke among patients with multiple sclerosis. Eur J Neurol (2015) 22:500–6.10.1111/ene.12598 25443663 [OpenAIRE] [PubMed] [DOI]
5 Malanga GA Gangemi E. Intracranial venous thrombosis in a patient with multiple sclerosis. A case report and review of contraceptive alternatives in patients with disabilities. Am J Phys Med Rehabil (1994) 73:283–5.10.1097/00002060-199407000-00011 8043252 [OpenAIRE] [PubMed] [DOI]
6 Albucher JF Vuillemin-Azaïs C Manelfe C Clanet M Guiraud-Chaumeil B Chollet F. Cerebral thrombophlebitis in three patients with probable multiple sclerosis. Role of lumbar puncture or intravenous corticosteroid treatment. Cerebrovasc Dis (1999) 9:298–303.10.1159/000015982 10473914 [OpenAIRE] [PubMed] [DOI]
7 Städler C Vuadens P Dewarrat A Janzer R Uske A Bogousslavsky J. Cerebral venous thrombosis after lumba r puncture and intravenous steroids in two patients with multiple sclerosis. Rev Neurol (Paris) (2000) 156:155–9. [OpenAIRE]
8 Vandenberghe N Debouverie M Anxionnat R Clavelou P Bouly S Weber M. Cerebral venous thrombosis in four patients with multiple sclerosis. Eur J Neurol (2003) 10:63–6.10.1046/j.1468-1331.2003.00513.x 12534995 [OpenAIRE] [PubMed] [DOI]
9 Allen NB Lichtman JH Cohen HW Fang J Brass LM Alderman MH. Vascular disease among hospitalized multiple sclerosis patients. Neuroepidemiology (2008) 30:234–8.10.1159/000128103 18437030 [OpenAIRE] [PubMed] [DOI]
10 Tsau S Emerson MR Lynch SG LeVine SM. Aspirin and multiple sclerosis. BMC Med (2015) 13:153.10.1186/s12916-015-0394-4 [OpenAIRE] [DOI]
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |